Funded Awards – November 2018

Funded Awards
PI Agency Title
Fahd Ahmad NIH/R01/Nationwide Children’s Hospital Development and Testing of a Pediatric Cervical Spine …
Juliane Bubeck Wardenburg NIH/R01 Enterotoxigenic B. fragilis Acquisition in Disease Sus…
Todd Druley Alex’s Lemonade Stand Foundation/Innovation Award RNA-ECS to quantify rare clonal RNA species at diagnos…
Sarah Garwood Missouri Foundation for Health Support in Schools for Transgender Children and Adoles…
Robert Hayashi NIH/R01/Vanderbilt University Medical Center Research Into The Visual Endpoints and RB Health Outco…
Jessica Pittman Cystic Fibrosis Foundation Therapeutics, Inc./Seattle Children’s Hospital TEACH Trial: Testing the Effect of Adding CHronic Azit…
Michael Thompson WashU NORC/Pilot and Feasibility Program Role of Transmission of Microbiome on Impact of Matern…
Kristine Wylie NIH/R01 The Vaginal Microbiome, Maternal Response, and Preterm…
Funded Awards
Funded Grants September 2021

PI Agency Title Megan Cooper NIH/ UG3/UH3/Baylor College of Medicine Safety and Efficacy of Itacitinib in treatment of JAK/STAT gain of function disorders Amjad Horani CDI Mechanisms of Primary Ciliary Dyskinesia Cynthia Ortinau Brain & Behavior Research Foundation Association of Parental Psychological Distress with Brain and Neurodevelopment in Congenital Heart …

Funded Awards
Funded Grants August 2021

PI Agency Title Fahd Ahmad NIH/CCHMC EMS for Children: Pediatric Emergency Care Applied Research Network (PECARN)  Jonathan Cooper NIH/R56 Characterizing and testing the efficacy of AAV-mediated gene therapy in a novel CRISPR/Cas9 generated sheepmodel of Cln1 disease. Jorge Di Paola NIH/R01/Ohio State University A Reversible Aptamer Based Therapeutic to Treat …

Funded Awards
Funded Grants July 2021

PI Agency Title Mohamed Abdelbaki EIF/The Hospital for Sick Children 3CI Study: Childhood Cancer Combination Immunotherapy. Phase 1b and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers Amy Armstrong Aflac Foundation/Children’s Healthcare of Atlanta A Maintenance Protocol of Sirolimus in …